Influenza Vaccine Market Status and Trend Analysis 2017-2026
- Report Code : 99S2203723
- Published On: Dec, 2020
- Category : Food & Beverages
- Pages : 109
-
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry .
The global Influenza Vaccine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Influenza Vaccine market segmented into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Others
Based on the end-use, the global Influenza Vaccine market classified into
Children
Adults
Elderly
Pregnancy
Based on geography, the global Influenza Vaccine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan
-
With tables and figures helping analyze worldwide Influenza Vaccine market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 RESEARCH SCOPE1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INFLUENZA VACCINE INDUSTRY2.1 Summary about Influenza Vaccine Industry
2.2 Influenza Vaccine Market Trends
2.2.1 Influenza Vaccine Production & Consumption Trends
2.2.2 Influenza Vaccine Demand Structure Trends2.3 Influenza Vaccine Cost & Price
3 MARKET DYNAMICS3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Trivalent Influenza Vaccine
4.2.2 Quadrivalent Influenza Vaccine
4.2.3 Others4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Children
4.3.2 Adults
4.3.3 Elderly
4.3.4 Pregnancy
5 NORTH AMERICA MARKET SEGMENT5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Trivalent Influenza Vaccine
5.2.2 Quadrivalent Influenza Vaccine
5.2.3 Others5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Children
5.3.2 Adults
5.3.3 Elderly
5.3.4 Pregnancy5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Trivalent Influenza Vaccine
6.2.2 Quadrivalent Influenza Vaccine
6.2.3 Others6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Children
6.3.2 Adults
6.3.3 Elderly
6.3.4 Pregnancy6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Trivalent Influenza Vaccine
7.2.2 Quadrivalent Influenza Vaccine
7.2.3 Others7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Children
7.3.2 Adults
7.3.3 Elderly
7.3.4 Pregnancy7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Trivalent Influenza Vaccine
8.2.2 Quadrivalent Influenza Vaccine
8.2.3 Others8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Children
8.3.2 Adults
8.3.3 Elderly
8.3.4 Pregnancy8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Trivalent Influenza Vaccine
9.2.2 Quadrivalent Influenza Vaccine
9.2.3 Others9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Children
9.3.2 Adults
9.3.3 Elderly
9.3.4 Pregnancy9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS10.1 Brief Introduction of Major Players
10.1.1 GSK
10.1.2 Sinovac
10.1.3 Changsheng
10.1.4 CCBIO
10.1.5 Aleph Biomedical
10.1.6 Sanofi
10.1.7 Lanzhou Institute Of Biological Product
10.1.8 Siobp
10.1.9 Hualan Bio
10.1.10 Tianyuan Bio-Pharma
10.1.11 Vaxtec
10.1.12 Hissen
10.1.13 Abbott
10.1.14 Novartis
10.1.15 Tasly&Jenner
10.1.16 Tiantan10.2 Influenza Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 GSK
10.2.2 Sinovac
10.2.3 Changsheng
10.2.4 CCBIO
10.2.5 Aleph Biomedical
10.2.6 Sanofi
10.2.7 Lanzhou Institute Of Biological Product
10.2.8 Siobp
10.2.9 Hualan Bio
10.2.10 Tianyuan Bio-Pharma
10.2.11 Vaxtec
10.2.12 Hissen
10.2.13 Abbott
10.2.14 Novartis
10.2.15 Tasly&Jenner
10.2.16 Tiantan10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
-
The Influenza Vaccine Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
A large number of Global Influenza Vaccine players are focusing on individualized and innovative technologies that will provide the necessary impetus for profit and growth in the coming years.
Depending upon the type of applications, the Influenza Vaccine Market has been segmented into
From 2025 to 2030, the Influenza Vaccine Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the Influenza Vaccine Market across the extensive corporate landscape.
The Influenza Vaccine study focuses on shifting market dynamics, geopolitical and regulatory regulations, and key players' strategies to carefully analyze demand at risk across multiple industry categories.
